Kanoria Chemicals & Industries Limited (BOM:506525)
India · Delayed Price · Currency is INR 79.75
+2.96 (3.85%)
At close: Feb 13, 2026
BOM:506525 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Revenue | 16,733 | 15,367 | 14,751 | 15,784 | 13,691 | 10,949 |
Revenue Growth (YoY) | 13.96% | 4.18% | -6.55% | 15.29% | 25.05% | 8.97% |
Cost of Revenue | 11,818 | 10,807 | 10,080 | 11,299 | 9,651 | 7,362 |
Gross Profit | 4,915 | 4,560 | 4,671 | 4,485 | 4,040 | 3,586 |
Selling, General & Admin | 2,451 | 2,461 | 2,422 | 2,193 | 2,019 | 1,662 |
Other Operating Expenses | 1,905 | 1,781 | 1,643 | 1,566 | 1,338 | 984.52 |
Operating Expenses | 5,008 | 4,868 | 4,659 | 4,348 | 3,929 | 3,227 |
Operating Income | -93.07 | -307.67 | 11.98 | 137.03 | 110.66 | 359.43 |
Interest Expense | -412.57 | -413.37 | -378.15 | -322.41 | -213.57 | -300.96 |
Interest & Investment Income | 5.82 | 5.82 | 3.07 | 1.94 | 4.14 | 14.43 |
Currency Exchange Gain (Loss) | 31.97 | 31.97 | -78.23 | -1.28 | 212.6 | 111.38 |
Other Non Operating Income (Expenses) | -18.14 | -31.94 | -21.9 | -76.22 | 3.12 | -9.6 |
EBT Excluding Unusual Items | -485.99 | -715.19 | -463.23 | -260.94 | 116.95 | 174.68 |
Gain (Loss) on Sale of Investments | -2.93 | -2.93 | 132.49 | 36.44 | 1.19 | -22.9 |
Gain (Loss) on Sale of Assets | 40.02 | 40.02 | 22.8 | 98.21 | 7.87 | -1.85 |
Asset Writedown | - | - | - | - | - | -7.9 |
Other Unusual Items | -294.44 | -294.44 | - | 4.16 | 5.33 | -27.79 |
Pretax Income | -743.34 | -972.54 | -307.94 | -122.13 | 131.34 | 114.24 |
Income Tax Expense | 111.11 | 117.91 | 209.16 | 6.7 | 109.01 | -45.65 |
Earnings From Continuing Operations | -854.45 | -1,090 | -517.1 | -128.83 | 22.33 | 159.89 |
Earnings From Discontinued Operations | 1,269 | 8.98 | -35.69 | - | - | - |
Net Income to Company | 414.73 | -1,081 | -552.79 | -128.83 | 22.33 | 159.89 |
Minority Interest in Earnings | 113.1 | 245.5 | 168.83 | 41.17 | 45.93 | -14.66 |
Net Income | 527.83 | -835.97 | -383.96 | -87.66 | 68.26 | 145.23 |
Net Income to Common | 527.83 | -835.97 | -383.96 | -87.66 | 68.26 | 145.23 |
Net Income Growth | - | - | - | - | -53.00% | - |
Shares Outstanding (Basic) | 44 | 44 | 44 | 44 | 44 | 44 |
Shares Outstanding (Diluted) | 44 | 44 | 44 | 44 | 44 | 44 |
EPS (Basic) | 12.08 | -19.13 | -8.79 | -2.01 | 1.56 | 3.32 |
EPS (Diluted) | 12.08 | -19.13 | -8.79 | -2.01 | 1.56 | 3.32 |
EPS Growth | - | - | - | - | -53.00% | - |
Free Cash Flow | - | -800.11 | -432.01 | -317.64 | 402.19 | 548.15 |
Free Cash Flow Per Share | - | -18.31 | -9.89 | -7.27 | 9.21 | 12.54 |
Dividend Per Share | - | - | - | - | 1.000 | - |
Gross Margin | 29.37% | 29.67% | 31.66% | 28.42% | 29.51% | 32.76% |
Operating Margin | -0.56% | -2.00% | 0.08% | 0.87% | 0.81% | 3.28% |
Profit Margin | 3.15% | -5.44% | -2.60% | -0.56% | 0.50% | 1.33% |
Free Cash Flow Margin | - | -5.21% | -2.93% | -2.01% | 2.94% | 5.01% |
EBITDA | 537.21 | 298.97 | 587.1 | 713.84 | 664.22 | 939.81 |
EBITDA Margin | 3.21% | 1.95% | 3.98% | 4.52% | 4.85% | 8.58% |
D&A For EBITDA | 630.28 | 606.64 | 575.12 | 576.81 | 553.56 | 580.38 |
EBIT | -93.07 | -307.67 | 11.98 | 137.03 | 110.66 | 359.43 |
EBIT Margin | -0.56% | -2.00% | 0.08% | 0.87% | 0.81% | 3.28% |
Effective Tax Rate | - | - | - | - | 83.00% | - |
Revenue as Reported | 16,839 | 15,459 | 14,943 | 15,888 | 13,980 | 11,068 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.